Expert Reaction

EXPERT REACTION: Gene-edited cell therapy saves baby girl from leukeamia

Publicly released:
Australia; QLD
CC:0
CC:0

A baby girl in the UK has been cleared of leukaemia following compassionate treatment with an experimental therapy which used gene-edited cells. It is the first time a therapy using the gene-editing technology TALENs (transcription activator-like effector nucleases) has been used in a human. Previously only tested in mice, the treatment was given on compassionate grounds when the baby girl did not respond to existing treatments. The unpublished results will be presented at the American Society of Hematology in December.

Media release

From:

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Professor Peter Koopman is from The University of Queensland’s Institute for Molecular Bioscience

This treatment is an astonishing example of the power of gene editing technology. Blood diseases are especially suitable for this type of treatment – the relevant cells can be readily obtained from the patient, are already separated (as opposed to being relatively inaccessible in a solid organ), can be modified and amplified, and replaced where they need to be. Time will tell how widely this kind of treatment can be used for diseases affecting other organs.

Genome editing technologies can sometimes cause unintended changes in the DNA in addition to the desired change. A particularly clever aspect of the way this treatment was designed is that some time later, the engineered cells can themselves be removed from the body, virtually eliminating the already small risk that those cells themselves may cause adverse effects

Last updated:  03 Nov 2016 7:28pm
Contact information
Contact details are only visible to registered journalists.
Declared conflicts of interest None declared.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Media Release Great Ormond Street Hospital, Web page
Research American Society of Hematology, Web page Conference abstract
Other UK Science Media Centre, Web page The UK SMC produced a Factsheet on genome editing which is available here
Journal/
conference:
American Society of Hematology
Organisation/s: Australian Science Media Centre
Funder:
Media Contact/s
Contact details are only visible to registered journalists.